|1||NCT03366142||Recruiting||Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology||
||20||All||12 Years to 65 Years (Child, Adult, Older Adult)||NCT03366142||180022
|June 26, 2018||January 31, 2021||May 31, 2021||December 8, 2017||June 21, 2018||
|2||NCT00514098||Recruiting||Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials||
||Other / NIH||
||500||Female||Child, Adult, Older Adult||NCT00514098||MTN-015
|August 2008||November 2020||November 2020||August 9, 2007||August 30, 2017||
† Study has passed its completion date and status has not been verified in more than two years.